跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
REGIOCIT - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
REGIOCIT
Authorized
STANDARD
REGIOCIT
Vantive ULC
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
22bc696c3cf06d88
Company
Vantive ULC
Type
Standard
Approval Details
Approval Id
22bc696c3cf06d88
Drug Approval Canada Name
REGIOCIT
Product Name
REGIOCIT
Status
Marketed
Status Date
2024-05-06
Original Market Date
2020-07-27
Din
02496755
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Extracorporeal
Schedule
Ethical
Ahfs
40:34.00*
Atc Original
B05ZB HEMOFILTRATES
Atc Name
b 05 zb
Aig Number
0262055001
Company Name
Vantive ULC
Company Address
6675 Millcreek Drive, Unit 2, Mississauga, Ontario, Canada, L5N 5M4
Active Ingredients
SODIUM CHLORIDE
5.03 G / L
SODIUM CITRATE
5.29 G / L
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
22bc696c3cf06d88
Type
Standard
Back to Health Canada Approvals